Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1267269.RAPVXfVHvEXU5gAF2sU82bcwduQm6aQbbELB_7QLW27lc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1267269.RAPVXfVHvEXU5gAF2sU82bcwduQm6aQbbELB_7QLW27lc130_assertion type Assertion NP1267269.RAPVXfVHvEXU5gAF2sU82bcwduQm6aQbbELB_7QLW27lc130_head.
- NP1267269.RAPVXfVHvEXU5gAF2sU82bcwduQm6aQbbELB_7QLW27lc130_assertion description "[Most of the results described above were obtained in CRC; however, when we extended our observations to tumor cell lines of different origin, we found that SMYD3 inhibitors are also effective in other cancer types, such as lung, pancreatic, prostate, and ovarian.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267269.RAPVXfVHvEXU5gAF2sU82bcwduQm6aQbbELB_7QLW27lc130_provenance.
- NP1267269.RAPVXfVHvEXU5gAF2sU82bcwduQm6aQbbELB_7QLW27lc130_assertion evidence source_evidence_literature NP1267269.RAPVXfVHvEXU5gAF2sU82bcwduQm6aQbbELB_7QLW27lc130_provenance.
- NP1267269.RAPVXfVHvEXU5gAF2sU82bcwduQm6aQbbELB_7QLW27lc130_assertion SIO_000772 25728514 NP1267269.RAPVXfVHvEXU5gAF2sU82bcwduQm6aQbbELB_7QLW27lc130_provenance.
- NP1267269.RAPVXfVHvEXU5gAF2sU82bcwduQm6aQbbELB_7QLW27lc130_assertion wasDerivedFrom befree-2016 NP1267269.RAPVXfVHvEXU5gAF2sU82bcwduQm6aQbbELB_7QLW27lc130_provenance.
- NP1267269.RAPVXfVHvEXU5gAF2sU82bcwduQm6aQbbELB_7QLW27lc130_assertion wasGeneratedBy ECO_0000203 NP1267269.RAPVXfVHvEXU5gAF2sU82bcwduQm6aQbbELB_7QLW27lc130_provenance.